Recent Quotes

My Watchlist

Top Indices

Articles published by Pharmaceutical Strategies Group

Pharmaceutical Strategies Group Publishes 2025 Pharmacy Benefit Manager Customer Satisfaction Report

September 23, 2025

From Pharmaceutical Strategies Group

Via Business Wire

Annual spending on specialty drugs continues to increase but at a slower pace than prior years, driven in part by biosimilar adoption.

August 05, 2025

From Pharmaceutical Strategies Group

Via Business Wire

PSG Releases 2025 Drug Benefit Design Report: PBM Unbundling Gains Momentum and Payers Navigate GLP-1 Coverage Decisions Amid Rising Costs

June 10, 2025

From Pharmaceutical Strategies Group

Via Business Wire

Payers Seeking Innovative Solutions to Control Specialty Drug Costs as Pharmacy Benefit Landscape Evolves Rapidly

April 28, 2025

From Pharmaceutical Strategies Group

Via Business Wire

Pharmaceutical Strategies Group Publishes 2024 Pharmacy Benefit Manager Customer Satisfaction Report

September 18, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Pharmaceutical Strategies Group Launches First-in-Class Technology Solution For Healthcare Payers

September 10, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Pharmaceutical Strategies Group Releases Artemetrx State of Specialty Spend and Trend Report

July 25, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Pharmaceutical Strategies Group Publishes Annual Drug Benefit Design Report for 2024

June 11, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Pharmaceutical Strategies Group Announces Strategic Leadership Enhancements to Meet Growing Client Needs

May 06, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) Found

April 29, 2024

From Pharmaceutical Strategies Group

Via Business Wire

Survey: Satisfaction With Pharmacy Benefits Managers Hits 9-Year Low

September 14, 2023

From Pharmaceutical Strategies Group

Via Business Wire

State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group

July 25, 2023

From Pharmaceutical Strategies Group

Via Business Wire

PSG Announces Results of Highly Comprehensive Pharmacy Benefit Manager Survey

October 19, 2022

From Pharmaceutical Strategies Group

Via Business Wire

PSG Announces New Features Designed to Support Biosimilar Strategy

August 29, 2022

From Pharmaceutical Strategies Group

Via Business Wire

Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group

August 23, 2022

From Pharmaceutical Strategies Group

Via Business Wire

Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group

June 22, 2022

From Pharmaceutical Strategies Group

Via Business Wire

Trends in Specialty Benefit Design Report Released by Pharmaceutical Strategies Group

May 02, 2022

From Pharmaceutical Strategies Group

Via Business Wire

Results of Comprehensive PBM Customer Satisfaction Research Released by Pharmaceutical Strategies Group

November 10, 2021

From Pharmaceutical Strategies Group

Via Business Wire

New Product Launch: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor

September 23, 2021

From Pharmaceutical Strategies Group

Via Business Wire

Proprietary Report on State of Specialty Spend and Trend Released by Pharmaceutical Strategies Group

August 12, 2021

From Pharmaceutical Strategies Group

Via Business Wire

Results of Comprehensive PBM Customer Satisfaction Research Released by Pharmaceutical Strategies Group

May 26, 2021

From Pharmaceutical Strategies Group

Via Business Wire

Modernized Integrated Data Technology Platform, Artemetrx, Now Available to Proactively Manage Drug Costs and Clinical Outcomes

April 14, 2021

From Pharmaceutical Strategies Group

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.